Funding outcome

A double-blind placebo-controlled trial of Metformin in individuals with Fragile X Syndrome

Program Type (Grant): Donor Designated
Applicant Name: Bolduc, Francois
Competition Cycle: 2018-04
Start Date: 2018-03-01
End Date: 2027-07-27
Institutional Sponsor: Medicine & Dentistry-Pediatrics
WCHRI Funder: SCHF
Total WCHRI Funding Commitment: $1,264,346.00
Return to Funding outcomes